Clinical trial
Autologous Stem Cell Rescue for Primary Amyloidosis
NCT00186407 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00186407 |
|---|---|
| Title | Autologous Stem Cell Rescue for Primary Amyloidosis |
| Official title | High Dose Chemotherapy and Autologous Stem Cell Rescue for Primary Amyloidosis |
| Lead sponsor | Stanford University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Amyloidosis, Blood and Marrow Transplant (BMT) |
| Intervention type | Procedure |
| Interventions | high dose chemo then auto hematopoietic cell transplant |
| Enrollment | 50 |
| Start date | Apr 1, 1998 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2010 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 14, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: